ArticleEJNMMI research2017
Effective dose estimation for oncological and neurological PET/CT procedures.
Article in EJNMMI research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.
- Application of immunoPET imaging to enhance head and neck squamous cell carcinoma clinical management.Frontiers in oncology · 2025Pooled it
- Estimation of the effective dose in torsoEJNMMI physics · 2026Article
- Generative restoration for cardiac PET attenuation correction: a two-stage 3D DDIM framework optimizing fidelity and clinical controllability.EJNMMI physics · 2026Article
- Effects of Scout Direction, Off-Centering, and Scout Imaging Parameters on Radiation Dose Modulation in CT.Tomography (Ann Arbor, Mich.) · 2026Article
- Human subject study of a transmission-aided attenuation correction for precision PET neuroimaging.EJNMMI physics · 2025Article
- Tryptophan Kynurenine Pathway-Based Imaging Agents for Brain Disorders and Oncology-From Bench to Bedside.Biomolecules · 2025Review
- Artificial intelligence-based joint attenuation and scatter correction strategies for multi-tracer total-body PET.EJNMMI physics · 2024Article
- Ultra-low-dose CT for attenuation correction: dose savings and effect on PET quantification for protocols with and without tin filter.EJNMMI physics · 2023Article
- Simultaneous quantitative imaging of two PET radiotracers via the detection of positron-electron annihilation and prompt gamma emissions.Nature biomedical engineering · 2023Article
- SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations.Pediatric radiology · 2023Review
- A systematic review and meta-analysis on the radiation dose of computed tomography in hybrid nuclear medicine imaging.EJNMMI physics · 2023Review
- Review
- Using domain knowledge for robust and generalizable deep learning-based CT-free PET attenuation and scatter correction.Nature communications · 2022Article
- Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.Pharmaceutics · 2022Article
- Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET.European journal of nuclear medicine and molecular imaging · 2022Article
- Conversion from dose length product to effective dose for the CT component of whole-body PET/CT.Annals of nuclear medicine · 2022Article
- Dynamic PET imaging with ultra-low-activity ofEuropean journal of nuclear medicine and molecular imaging · 2021Article
- First clinical experience of 106 cm, long axial field-of-view (LAFOV) PET/CT: an elegant balance between standard axial (23 cm) and total-body (194 cm) systems.European journal of nuclear medicine and molecular imaging · 2021Article
- Cumulative radiation doses from recurrent PET-CT examinations.The British journal of radiology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to retrospectively evaluate the patient effective dose (ED) for different PET/CT procedures performed with a variety of PET radiopharmaceutical compounds. PET/CT studies of 210 patients were reviewed including Torso (n = 123), Whole body (WB) (n = 36), Head and Neck Tumor (HNT) (n = 10), and Brain (n = 41) protocols with
resultsTotal ED (mean ± SD) for Torso-
conclusionsThe mean ED for body and brain PET/CT protocols with different radiopharmaceuticals ranged between 4.6 and 20.0 mSv. The major contributor to total ED for body protocols is CT, whereas for brain studies, it is the PET radiopharmaceutical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.